James L. LaBelle to Neoplasm, Residual
This is a "connection" page, showing publications James L. LaBelle has written about Neoplasm, Residual.
Connection Strength
0.047
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
Score: 0.047